IL Pharmaceuticals

Redhill Biopharma Ltd (RDHL)

Track

Track

Redhill Biopharma Ltd experienced limited insider activity recently. Chief Operating Officer Gilead Raday executed a sell transaction valued at 1,413 USD on July 10, 2026. This follows a previous divestment in April. The stock price has declined 42.2% over the past ninety days, reflecting significant downward pressure amidst these executive sales.
Ticker: RDHL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Raday Gilead Chief Operating Officer Officer
Transaction date
Sale
Price
152.47
Quantity 35,693 +47.2%
Value US$3,191,897
Raday Gilead Chief Operating Officer Officer
Transaction date
Sale
Price
232.34
Quantity 57,003 +32.4%
Value US$4,817,785
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-10 S Sale
Raday Gilead

Chief Operating Officer

Officer
35,693 +47.2%
152.47
US$3,191,897 		35,693 +47.2% 152.47 US$3,191,897
2026-04-22 2026-04-06 S Sale
Raday Gilead

Chief Operating Officer

Officer
57,003 +32.4%
232.34
US$4,817,785 		57,003 +32.4% 232.34 US$4,817,785
Explore more

More insider trading research around Redhill Biopharma Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity